HomeNewsBusinessMarketsCoronavirus woes hit metal stocks, but Tata Steel & JSW Steel may ride the storm

Coronavirus woes hit metal stocks, but Tata Steel & JSW Steel may ride the storm

Ambit has initiated a buy call on Tata Steel with a target of Rs 550 which translates into an upside of over 40 percent from March 3 closing level of Rs 387 on the BSE.

March 05, 2020 / 10:55 IST
Story continues below Advertisement

The Nifty Metal index fell about 10 percent during the January 31-March 3 perid, largely impacted by the global volatility due to Coronavirus which has led to the destruction in demand. But there is still a silver lining for Tata Steel and JSW Steel.

“While being conscious of the near-term demand destruction emanating from Coronavirus, we see the supportive environment for metals from 2HCY21 on the back of expected Chinese stimulus, credit impulse, and global liquidity support,” Ambit Capital said in a report.

Story continues below Advertisement

“We see global and domestic mill utilization scaling up through FY22, supporting spreads. Both Tata Steel (TSL) and JSW Steel (JSW) should generate >20% EBIDTA CAGR through FY22E,” said the report.

As an early cycle, metal, steel stand to benefit the most from Chinese infrastructure spend. Global cyclical recovery and re-stocking should provide added support. On the valuations front, peak earnings in FY22, 10-15% is below expectations.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show